Comparative phenotype analysis

• US 6,472,201 B1
• Filed: 12/29/2000
• Issued: 10/29/2002
• Est. Priority Date: 04/12/1995
• Status: Expired due to Term

• Current Assignee: Biolog, Inc.
• Original Assignee: Biolog, Inc.
• Inventors: Bochner, Barry, Panomitros, Eugenia
• Primary Examiner(s): TATE, CHRISTOPHER ROBIN
• Application Number:
  US09/752,168
• Time in Patent Office: 669 Days
• Field of Search: 435/4, 435/29, 435/34, 435/32, 435/7.31, 435/7.32, 435/822, 435/911, 435/288.4
• US Class Current: 435/288.4
• CPC Class Codes: C12Q 1/04 Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor C12Q1/6897 takes precedence
• CPC Class Codes: C12Q 2304/20 Redox indicators
• CPC Class Codes: C12Q 2304/22 Resazurin; Resorufin
• CPC Class Codes: C12Q 2304/24 Tetrazolium; Formazan
• CPC Class Codes: G01N 2035/00148 Test cards, e.g. Biomerieux or McDonnel multiwell test cards
• CPC Class Codes: G01N 2333/36 from Actinomyces; from Streptomyces (G)
• CPC Class Codes: Y10S 435/81 Packaged device or kit
• CPC Class Codes: Y10S 435/822 using bacteria or actinomycetales
• CPC Class Codes: Y10S 435/911 using fungi
• CPC Class Codes: Y10S 435/975 Kit

Abstract

The present invention relates to growing and testing microorganisms in a multitest format which utilizes a gel forming matrix for the rapid screening of clinical and environmental cultures. The present invention is suited for the characterization of commonly encountered microorganisms (e.g., E. coli, S. aureus, etc.), as well as commercially and industrially important organisms from various and diverse environments (e.g., the present invention is particularly suited for the growth and characterization of the actinomycetes and fungi). The present invention is also particularly suited for comparative analysis of phenotypic differences between cell types, including strains of microorganisms that have been designated as the same genus and species, as well as other cell types (e.g., mammalian, insect, and plant cells).

Claims

1. A testing system for measuring at least 95 nutritional phenotypes of at least one cell type, comprising a testing device having a plurality of testing wells wherein said testing wells contain at least one test substrate selected from the group consisting of nitrogen sources selected from the group consisting of nitrogen-containing compounds, phosphorus sources selected from the group consisting of phosphorus-containing compounds, sulfur sources selected from the group consisting of sulfur-containing compounds, and auxotrophic supplements selected from the group consisting of amino acids, vitamins, polyamines, lactones, fatty acids, nucleic acid bases, nucleosides and nucleotides;

inoculating fluid comprising a gelling agent, under conditions such that said gelling agent remains ungelled; and

an instrument capable of incubating and recording the response of said at least one cell type placed in said testing device.

2. The testing system of claim 1, wherein said nitrogen sources are selected from the group consisting of D-alanine, L-alanine, L-arginine, D-asparagine, L-asparagine, D-aspartic acid, L-aspartic acid, L-cysteine, L-cystine, D-glutamic acid, L-glutamic acid, L-glutamine, glycine, L-histidine, L-homoserine, D,L-β

-hydroxy-glutamic acid, L-isoleucine, L-leucine, L-phenylalanine, L-proline, D-serine, L-serine, L-tryptophan, L-tyrosine, glutathione, cytosine, D-glucosamine, D-galactosamine, D-mannosamine, N-acetyl-D-glucosamine, N-acetyl-D-galactosamine, N-acetyl-D-mannosamine, methylamine, ethylamine, butylamine, isobutylamine, amylamine, ethanolamine, ethylenediamine, pentamethylenediamine, hexamethylenetriamine, phenylethylamine, tyramine, piperidine, pyrrole, β

-alanine, acetylglycocol, phenylglycine-o-carbonic acid, α

-aminovaleric acid, γ

-aminovaleric acid, α

-aminoisovaleric acid, γ

-aminoisovaleric acid, α

-aminocaproic acid, γ

-aminocaprylic acid, acetamide, lactamide, glucuronamide, formamide, propionamide, methoxylamide, thioacetamide, cyanate, diethylurea, tetraethylurea, biuret, alloxan, alloxantine, allantoin, theobromine, ammonium chloride, sodium nitrite, potassium nitrate, urea, glutathione (reduced form), alloxan, L-citrulline, putrescine, L-ornithine, agmatine, L-lysine, L-methionine, L-threonine, L-valine, D-lysine, D-valine, N-acetyl-glycine, L-pyroglutamic acid, histamine, adenosine, deoxyadenosine, cytosine, adenine, thymine, thymidine, uracil, uridine, deoxycytidine, cytidine, guanine, guanosine, xanthine, xanthosine, inosine, DL-α

-amino-n-butyic acid, γ

-amino-n-butyric acid, ε

-amino-n-caproic acid, DL-α

-amino-caprylic acid, hippuric acid, parabanic acid, uric acid, urocanic acid, δ

-amino-n-valeric acid, 2-amino-valeric acid, gly-glu, ala-gly, ala-his, ala-thr, gly-met, gly-gln, ala-gln, gly-ala, gly-asn, and met-ala.

3. The testing system of claim 1, wherein said phosphorus sources are selected from the group consisting of phosphate, pyrophosphate, trimetaphosphate, tripolyphosphate, hypophosphite, thiophosphate, adenosine 2′

-monophosphate, adenosine 3′

-monophosphate, adenosine 5′

-monophosphate, adenosine 2′

;

3′

-cyclic monophosphate, adenosine 3′

;

5′

-cyclic monophosphate, dithiophosphate, DL-α

-glycero-phosphate, β

-glycero-phosphate, phosphatidyl glycerol, phosphoenol pyruvate, phosphocreatine, 2′

deoxy glucose 6-phosphate, guanosine 2′

-monophosphate, guanosine 3′

-monophosphate, guanosine 5′

-monophosphate, guanosine 2′

;

3′

-cyclic monophosphate, guanosine 3′

;

5′

-cyclic monophosphate, glucose 1-phosphate, glucose 6-phosphate, fructose 1-phosphate, fructose 6-phosphate, mannose 1-phosphate, mannose 6-phosphate, arabinose 5-phosphate, cytidine 2′

-monophosphate, cytidine 3′

-monophosphate, cytidine 5′

-monophosphate, cytidine 2′

;

3′

-cyclic monophosphate, cytidine 3′

;

5′

-cyclic monophosphate, glucosamine 1-phosphate, glucosamine 6-phosphate, phospho-L-arginine, O-phospho-D-serine, O-phospho-L-serine, O-phospho-D-tyrosine, O-phospho-L-tyrosine, uridine 2′

-monophosphate, uridine 3′

-monophosphate, uridine 5′

-monophosphate, uridine 2′

;

3′

-cyclic monophosphate, uridine 3′

;

5′

-cyclic monophosphate, O-phospho-L-threonine, inositol hexaphosphate, nitrophenyl phosphate, 2-aminoethyl phosphonate, 6-phosphogluconic acid, 2-phosphoglyceric acid, phosphoglycolic acid, phosphonoacetic acid, thymidine 3′

-monophosphate, thymidine 5′

-monophosphate, methylene diphosphonic acid, and thymidine 3′

;

5′

-cyclic monophosphate.

4. The testing system of claim 1, wherein said sulfur sources are selected from the group consisting of sulfate, thiosulfate, tetrathionate, thiophosphate, dithiophosphate, L-cysteine, cysteinyl-glycine, L-cysteic acid, cysteamine, L-cysteine-sulphinic acid, cystathionine, lanthionine, DL-ethionine, glutathione (reduced form), L-methionine, glycyl-DL-methionine, S-methyl-L-cysteine, L-methionine sulfoxide, L-methionine sulfone, taurine, N-acetyl-DL-methionine, N-acetyl cysteine, isethionate, thiourea, thiodiglycol, thioglycolic acid, thiodiglycolic acid, 1-dodecane-sulfonic acid, taurocholic acid, tetramethylene sulfone, hypotaurine, O-acetyl-serine, 3′

;

3′

thiodipropionic acid, L-djenkolic acid, and 2-mercaptoethylamine, metabisulfite, dithionite, polysufide, cystine, glycyl-cysteine, L-2-thiohistidine, and S-ethyl-cysteine.

5. The testing system of claim 1, wherein said auxotrophic supplements are selected from the group consisting of L-alanine, L-arginine, L-asparagine, L-aspartic acid, adenine, adenosine, 2′

-deoxyadenosine, adenosine 3′

;

5′

-cyclic monophosphate, adenosine 3′

-monophosphate, adenosine 5′

-monophosphate, L-cysteine, L-glutamic acid, L-glutamine, L-glycine, L-histidine, L-isoleucine, guanine, guanosine, 2′

-deoxyguanosine, guanosine 3′

;

5′

-cyclic monophosphate, guanosine 3′

-monophosphate, guanosine 5′

-monophosphate, L-leucine, L-lysine, L-methionine, L-phenylalanine, L-proline, L-serine, cytosine, cytidine, 2′

-deoxycytidine, cytidine 3′

;

5′

-cyclic monophosphate, cytidine 3′

-monophosphate, cytidine 5′

-monophosphate, L-tryptophan, L-tyrosine, L-threonine, L-valine, D-alanine, D-aspartic acid, thymine, thymidine, thymidine 3′

;

5′

-cyclic monophosphate, thymidine 3′

-monophosphate, thyrnidine 5′

-monophosphate, D-glutarnic acid, (5)4-amino-imidazole-4(5)-carboxamide, DL-α

,ε

-diaminopimelic acid, D-biotin, DL-α

-lipoic acid, caprylic acid, uracil, uridine, 2′

-deoxyuridine, uridine 3′

;

5′

-cyclic monophosphate, uridine 3′

-monophosphate, uridine 5′

-monophosphate, p-amino-benzoic acid, shikimic acid, molybdic acid, folic acid, α

-keto-isovaleric acid, D-pantothenic acid, hypoxanthine, inosine, 2′

-deoxyinosine, inosine 3′

;

5′

-cyclic monophosphate, inosine 3′

-monophosphate, inosine 5′

-monophosphate, thiamine, riboflavin, pyridoxal, pyridoxine, pyridoxamine, quinolinic acid, reduced glutathione, L-homoserine lactone, α

-ketobutyric acid, β

-nicotinarnide adenine dinucleotide, nicotinic acid, nicotinamide, N-α

-acetyl-L-ornithine, L-ornithine, L-citrulline, putrescine, spermidine, spermine, TWEEN®

20, TWEEN®

40, TWEEN®

60, TWEEN®

80, and δ

-amino-levulinic acid.

6. The testing system of claim 1, wherein said at least one test substrate is further selected from the group consisting of carbon sources selected from the group consisting of polymers, carbohydrates, acids, esters, amides, amines, alcohols, aldehydes, ketones, amino acids, peptides, and nucleosides.

7. The testing system of claim 6, wherein said carbon sources are selected from the group consisting of dextrin, TWEEN®

40, TWEEN®

60, TWEEN®

80, N-acetyl-D-galactosamine, N-acetyl-D-glucosamine, L-arabinose, D-fructose, L-fucose, D-galactose, α

-D-glucose, α

-D-lactose, maltose, D-mannitol, D-mannose, D-melibiose, β

-methyl-D-glucoside, L-rhamnose, D-sorbitol, D-trehalose, methyl pyruvate, mono-methyl succinate, acetic acid, D-galactonic acid lactone, D-galacturonic acid, D-gluconic acid, D-glucuronic acid, α

-ketobutyric acid, D,L-lactic acid, propionic acid, succinic acid, bromosuccinic acid, alaninamide, D-alanine, L-alanine, L-alanyl-glycine, L-asparagine, L-aspartic acid, glycyl-L-aspartic acid, glycyl-L-glutamic acid, D-serine, L-serine, inosine, uridine, thymidine, glycerol, D,L-α

-glycerol phosphate, glucose-1-phosphate, and glucose-6-phosphate, α

-cyclodextrin, adonitol, D-arabitol, cellobiose, i-erythritol, xylitol, citric acid, D-glucosaminic acid, β

-hydroxybutyric acid, γ

-hydroxybutyric acid, p-hydroxyphenylacetic acid, itaconic acid, α

-ketovaleric acid, malonic acid, quinic acid, sebacic acid, L-histidine, hydroxy L-proline, L-leucine, and D,L-carnitine, glycogen, D-psicose, succinamic acid, glucuronamide, gentiobiose, m-inositol, cis-aconitic acid, L-phenylalanine, L-pyroglutamic acid, phenylethylamine, putrescine, 2-amino ethanol, 2,3-butanediol, lactulose, D-raffinose, formic acid, α

-hydroxybutyric acid, L-glutamic acid, L-proline, sucrose, L-ormithine, turanose, α

-ketoglutaric acid, D-saccharic acid, L-threonine, γ

-aminobutyric acid and urocanic acid.

8. The testing system of claim 1, wherein said testing device comprises more than 95 testing wells.

9. The testing system of claim 1, wherein said testing wells further contain a gel-initiating agent and said gelling agent in said inoculating fluid remains ungelled until said at least one cell type is placed in said testing wells.

10. The testing system of claim 1, further comprising at least one antimicrobial.

11. The testing system of claim 10, wherein said at least one antimicrobial is present in said testing wells.

12. The testing system of claim 10, wherein said inoculating fluid further comprises said at least one antimicrobial.

13. The testing system of claim 1, further comprising at least one colorimetric indicator.

14. The testing system of claim 13, wherein said at least one calorimetric indicator is present in said testing wells.

15. The testing system of claim 13, wherein said inoculating fluid further comprises said at least one colorimetric indicator.

16. The testing system of claim 13, wherein said colorimetric indicator is selected from the group consisting of chromogenic compounds, fluorochromic compounds, fluorogenic compounds, pH indicators, oxidation-reduction indicators, and luminogenic compounds.

17. The testing system of claim 16, wherein said oxidation-reduction indicator comprises a tetrazolium dye.

18. The testing system of claim 16, wherein said oxidation-reduction indicator comprises redox purple.

19. The testing system of claim 1, wherein said inoculating fluid further comprises at least one additional substrate selected form the group consisting of carbon sources, nitrogen sources, phosphorus sources, sulfur sources, and auxotrophic supplements.

20. The testing system of claim 1, wherein said inoculating fluid further comprises microorganisms selected from the group consisting of bacteria and fungi.

21. The testing system of claim 1, further comprising a detection means, wherein said detecting is visual.

22. The testing system of claim 21, wherein said detecting is performed by an instrument.

23. The testing system of claim 22, wherein said instrument comprises a video camera.

24. The testing system of claim 21, wherein said detecting is conducted over time.